1/ I feel there are still some important points to make about this question of whether and how quickly Covid will become like a common cold
2/ The first point is CoV-2 is a respiratory virus. It spreads straight from your nose and throat to mine. This is a very distinct group of viruses with something surprising (and, really, unexplained) in common – the illnesses they cause are much more common in cold weather.
3/ They’re also mild in the vast majority of cases – so CoV-2 will be very unusual if it remains as pathogenic as this for long. (Though of course rhinovirus, adenovirus, parainfluenza etc regularly hospitalize children and others 👇)
4/ I think everyone agrees that we need to think about the “trade-off” model of the evolution of parasites: short-sighted selection says that the virus would become super-virulent. However long-sighted selection says it won’t be transmitted well if it’s *too* virulent.
5/ (As an example of trade-off in action, why are colds so such much more common than Ebola, Marburg & Lassa viral hemmorhagic fevers, which can all spread from person to person? Something either stops VHFs or makes them mild over time.)
6/ (Just as well, or complex life-forms might well be impossible.)
So clearly selection is reducing pathogenicity, at least in the extreme cases.
7/ Scientists talking about trade-off often say “if a virus is too virulent, it may kill its host too quickly”
True, but trade-off isn’t only or mainly about death. For viruses such as CoV-2 that AREN'T spread by insects etc, a crucial question is whether *mobility* is reduced.
8/ (Ewald, 1985, pointed out that viruses that are spread by vectors tend to be more virulent, p < 0.0005. He suggests that for them it doesn’t matter much whether the host moves around because the vectors can come to the host. doi.org/10.1146/annure…)
9/ So respiratory viruses need to both reduce their virulence, & have long incubation periods, so that their hosts remain infectious for longer
Since most resp viruses are mild, seems that (fortunately for us) a long incubation period IS correlated with mild symptoms in respvirs
10/ People often point out that other endemic viruses such as measles and smallpox remain virulent and have not become as mild as colds.
11/ However measles and smallpox occupy a different niche: they go through the lymphatic system, before getting into the blood. This probably slows them up and makes their hosts infectious for longer.
12/ Timing: so when will CoV-2 become like a common cold?
We don’t know but there are clues: the first is the autumn surge of colds, which is very common, shown below 👇
The highest number of colds all year can appear in early autumn – which is certainly not the coldest season
13/ The only reasonable explanation of this autumn surge that I know of – which is falsifiable – is that these viruses have adapted to the high summer temperatures, and they get “caught out” by a drop of a few degrees in autumn.
14/ So it seems viral pathogenicity can significantly adapt over a few months. Similarly, viral strains that come from the Tropics seem to become mild in a few months. See our paper for details doi.org/10.1002/rmv.22…
15/ So why isn’t CoV-2 already noticeably milder?
Here I want to have my argumentative cake & eat it by saying our interventions may possibly have slowed up up attenuation. Eg we may have enforced the wrong kind of track & trace:
16/ our relatively slow track & trace could have stopped the slow-burning, asymptomatic or mild strains, but allowed the more aggressive, fast-acting ones to proliferate. Could we have accidentally made things much worse?
17/ After all, 70% of respiratory viruses detected by Galanti and colleagues by multiplex PCR in New York City were asymptomatic (including influenza at ~50%) 👇doi.org/10.1017/S09502…
18/ Letting mild and asymptomatic infections spread could be very important in moderating this disease. In fact yuou could argue that only symptomatic people should take tests
19/ All fascinating !
Of course much of this is speculative, but most of it is falsifiable
1/ Omicron seems to be a strain that specializes in gaining entry to human cells by endocytosis (ie being engulfed by the cell rather like an amoeba engulfing its prey)
2/ Om's different from previous variants such as Delta because it doesn’t seem to fuse cell membranes (fusion allows other strains to gain entry to cells and to move into and infect neighboring cells) doi.org/10.1101/2021.1…
1🧵Thoughts on the timing of Covid-19.
Key points to note:
First, the extraordinary stability of CoV-2 during 2020
Second, a lot can be explained if CoV-2 in Wuhan mutated to become more TRANSMISSIBLE in Oct/Nov 2019 (rather like Omicron)
2/ As @mattwridley and @Ayjchan point out in their excellent #OriginOfCovid book, this may well have started with the authorities in Wuhan deciding to cover up a small local problem.
3/ How might events have unfolded?
Covid-19 started with either a lab-leak or a zoonotic spill-over. But when?
CoV-2 was extraordinarily stable from Jan 2020 to the arrival of Alpha in Nov 2020.
Fig 1 of Kanduc & Shoenfeld (2020) uses a very simple analysis: shows that CoV-2 shares many 6-chain amino acid sequences with human and mouse genomes, but not other genomes such as cow, pig, gorilla, chimp, rhesus monkey, fruit bat
2/ The same applies to polio, measles, dengue, influenza H1N1, smallpox, HPV, and Ebola viruses. Also bacterial pathogens like anthrax, plague and toxoplasmosis; all overlap more with mouse (and rat) than other animals.
3/ This implies we have frequently swapped pathogens with rodents - which we live very closely with. (Apparently bat experts say bats have the most dangerous viruses. But rodent experts say THEY, rodents, harbour the worst viruses!)
1/ Important observation: many respiratory viruses are much easier to culture at 33°C than 37°C – as predicted by temperature dependent viral tropism #TDVT
However, virologists normally put this down to the thermal sensitivity of the host CELLS – less interferon may be produced by cells at 33°C than 37°C doi.org/10.1073/pnas.1…
3/ Actually our immune defences do seem to be weaker when we breath cold air –this may explain the observation that standing still outdoors is correlated with increased mortality from respiratory disease (while outdoor exertion sufficient to cause sweating seems to be protective)
The problem is that we essentially have ONE observation - that hundreds of often unrelated viruses in all regions (outside the Tropics) with very diverse climates, have winter seasonality
2/
If we say the winter surge of colds in one place is due to eg school buses, business travel and humidity, but somewhere else it's sports events, snow and sunshine, we are cheating. We’re “overfitting” - we are using too many variables to model a 1-d phenomenon
3/
One reason I’m convinced that viruses moderate their pathogenicity much more than is often appreciated comes from observations of hemorrhagic fevers, which give fascinating insights
/1
People occasionally pick up viruses from animals especially rodents & bats. Usually they cause mild flu-like symptoms but here's the extraordinary thing: if they get a hold they often cause internal & external bleeding & are fatal – in spite of NOT being well-adapted to humans
/2
Ebola is one example. There are many others eg Rift Valley, Lujo, Bolivian and Brazilian hem. fevers. Ebola, Marburg, Crimean-Congo and Lassa hem. fevers can spread from person to person.
/3